This Article Full Text Full Text (PDF) Other Versions of this Article: JCM.02022-06v1 45/3/897    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Payan, C. Articles by Lunel, F. Search for Related Content PubMed PubMed Citation Articles by Payan, C. Articles by Lunel, F.

Human Papillomavirus Quantification in Urine and Cervical Samples by Using the Mx4000 and LightCycler General Real-Time PCR Systems

Département de Microbiologie-EA3882,¹ Service de Gynécologie, CHU Brest, France,³ Laboratoire de Virologie,² Service de Gynécologie-Obstetrique,⁴ Centre Antivénérien,⁵ Centre de Protection Maternelle et Infantile,⁶ Laboratoire de Cytologie, CHU Angers, France⁷

Received 30 September 2006/ Returned for modification 13 November 2006/ Accepted 5 January 2007

During the last decade, growing efforts have focused on human papillomavirus (HPV) detection using liquid hybridization, conventional PCR, and real-time PCR-based methods to increase the overall proportion of patients participating in cervical cancer screening procedures. We proposed a new general HPV DNA real-time PCR on the Mx4000 (Stratagene) and LightCycler (Roche Diagnostics) systems usable for both cervical scrape specimens and urine samples. A linear range was obtained from 5 DNA copies to 8 log₁₀ DNA copies/ml, and intra- and interassay variations were between 1.8 and 4%. Cervical carcinoma and HPV DNA screening was performed in 333 individual women referred for gynecological examination at the university hospitals of Angers and Brest and enrolled in the PapU study. Among cervical specimens (n = 333), 45% were positive for HPV DNA, with a mean viral load at 5.00 log/ml (± 1.73). Among urine samples (n = 177), 37% were positive with a significant 50-fold-lower mean viral load (3.77 ± 1.32 log/ml; P < 0.0001). Kappa agreement for HPV DNA between cervical and urine specimens was excellent (93%). Thus, we developed a highly sensitive and quantitative general HPV DNA real-time PCR method that allows mass screening of patients with HPV infection. The ongoing longitudinal and prospective multicenter PapU study should give us the opportunity to validate this method adapted to HPV DNA screening in urine samples in a larger population.

Published ahead of print on 17 January 2007.

This article has been cited by other articles:

• Mulrooney-Cousins, P. M., Michalak, T. I. (2008). Repeated Passage of Wild-Type Woodchuck Hepatitis Virus in Lymphoid Cells Does Not Generate Cell Type-Specific Variants or Alter Virus Infectivity. J. Virol. 82: 7540-7550 [Abstract] [Full Text]